Skip to main content
Clinical Trials/NCT05027503
NCT05027503CompletedNot Applicable

Investigation of the Effectiveness of the Hippotherapy Simulator Added to Respiratory Physiotherapy in Children and Adolescents with Cystic Fibrosis

Istanbul University - Cerrahpasa1 site in 1 country32 target enrollmentStarted: December 19, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
32
Locations
1
Primary Endpoint
Forced Vital Capacity (FVC)

Study Overview

Brief Summary

Cystic fibrosis (CF) is a genetic disease that affects many organs and systems, especially respiratory system problems due to lung damage. Patients often have difficulty in removing the sticky and viscous secretion that accumulates in the respiratory tract, and the risk of mortality increases with the development of respiratory failure. In patients with CF, exercise capacity, peripheral muscle strength, core endurance, flexibility, postural stability, physical activity level, and quality of life also decrease secondarily. Recently published guidelines recommend respiratory physiotherapy for coping with CF-related symptoms and recommend referral of patients to physical activity and exercise.

Hippotherapy simulator is a mechanical exercise tool that imitates the walking movement of a real horse and is used to increase physical fitness parameters.

This study aims to show the effects of exercises performed with a hippotherapy simulator in addition to respiratory physiotherapy on physical fitness, sputum production, physical activity and quality of life of children with CF.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
8 Years to 14 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Be in the 8-14 age range
  • •To be diagnosed with cystic fibrosis according to the American Cystic Fibrosis Association consensus report criteria
  • •Having mild (FEV1 ≥ 70% predictive) lung disease according to the disease severity classification in the annual report of the American Cystic Fibrosis Society
  • •To be able to produce phlegm

Exclusion Criteria

  • •Contracture or deformity,
  • •History of diagnosed orthopedic problems affecting mobility or musculoskeletal surgery
  • •History of previous lung or liver transplant
  • •Have diagnosed vision, hearing, vestibular or neurological problems that may affect balance,
  • •History of hospitalization in the last 1 month
  • •Patients who have participated in any exercise training program in the last 6 months

Arms & Interventions

Control Group

Active Comparator

Home-based respiratory physiotherapy will be applied twice a day and every day of the week for 8 weeks

Intervention: Respiratory Physiotherapy (Other)

Training Group

Experimental

In addition to home-based respiratory physiotherapy, 30 min exercises with the hippotherapy simulator will be done.

Intervention: Exercise with hippotherapy simulator (Other)

Training Group

Experimental

In addition to home-based respiratory physiotherapy, 30 min exercises with the hippotherapy simulator will be done.

Intervention: Respiratory Physiotherapy (Other)

Outcomes

Primary Outcomes

Forced Vital Capacity (FVC)

Time Frame: 8 weeks

Pulmonary Function Test

Forced Expiratory Volume in 1 second (FEV1)

Time Frame: 8 weeks

Pulmonary Function Test

Tiffeneau ratio (FEV1/FVC)

Time Frame: 8 weeks

Pulmonary Function Test

Peak Expiratory Flow (PEF)

Time Frame: 8 weeks

Pulmonary Function Test

Distance covered in six minute walk test

Time Frame: 8 weeks

Functional Capacity

Postural stability test score in Biodex Balance System SD

Time Frame: 8 weeks

Postural Stability

Limits of stability test score in Biodex Balance System SD

Time Frame: 8 weeks

Postural Stability

Secondary Outcomes

  • m. quadriceps strength(8 weeks)
  • Amount of sputum expelled (gr)(8 weeks)
  • Biering Sorenson Test(8 weeks)
  • Lateral Bridge Test(8 weeks)
  • Trunk Flexion Test(8 weeks)
  • Ease of expectoration(8 weeks)
  • Sense of chest congestion(8 weeks)
  • Sit and reach test(8 weeks)
  • Physical Activity Questionnaire for Children (PAQ-C)(8 weeks)
  • Cystic Fibrosis Questionnaire Revised (CFQ-R)(8 weeks)

Investigators

Sponsor
Istanbul University - Cerrahpasa
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Betül Çınar

Lecturer

Istanbul University - Cerrahpasa

Study Sites (1)

Loading locations...

Similar Trials